Get started
Author

Guanghao Zhu

Observed names: Guang-Hao Zhu, GuangHao ZHU, Guanghao ZHU, Guang‐Hao Zhu, Xueyan Hu, Zhu, Guanghao
Observed institutions: Huaibei Normal University, Shanghai Jiao Tong University, Fudan University, Ruijin Hospital, Shanghai University of Traditional Chinese Medicine, Changhai Hospital, Huazhong University of Science and Technology
ORCID: 0000-0001-9815-1939
Observed ORCID: 0000-0001-9815-1939
OpenAlex ID: A5081909934
The SARS‐CoV‐2 main protease (M pro ): Structure, function, and emerging therapies for COVID‐19
2022 · Qing Hu, Yuan Xiong, et al. · MedComm · 245
Discovery of naturally occurring inhibitors against SARS-CoV-2 3CLpro from Ginkgo biloba leaves via large-scale screening
2021 · Yuan Xiong, Guang-Hao Zhu, et al. · Fitoterapia · 79
Xanthohumol ameliorates drug-induced hepatic ferroptosis via activating Nrf2/xCT/GPX4 signaling pathway
2024 · Yanyan Deng, Xiayan Chu, et al. · Phytomedicine · 76
Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CLpro: Inhibition potentials, covalent binding sites and inhibitory mechanisms
2021 · Yuan Xiong, Guang-Hao Zhu, et al. · International Journal of Biological Macromolecules · 73
Targeting circ-0034880-enriched tumor extracellular vesicles to impede SPP1highCD206+ pro-tumor macrophages mediated pre-metastatic niche formation in colorectal cancer liver metastasis
2024 · Jing Zhou, Qing Song, et al. · Molecular Cancer · 64
PDF
Emerging Pharmacotherapeutic Strategies to Overcome Undruggable Proteins in Cancer
2023 · Yuqing Lu, Yuewen Yang, et al. · International Journal of Biological Sciences · 40
PDF
Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CLpro
2021 · Ruyu Wang, Qing Hu, et al. · International Journal of Biological Macromolecules · 40
A novel TICT-based near-infrared fluorescent probe for light-up sensing and imaging of human serum albumin in real samples
2022 · Yufan Fan, Fangyuan Wang, et al. · Chinese Chemical Letters · 37
Discovery and Characterization of the Naturally Occurring Inhibitors Against Human Pancreatic Lipase in Ampelopsis grossedentata
2022 · Xiao-Ya Qin, Xu-Dong Hou, et al. · Frontiers in Nutrition · 28
PDF
Discovery and characterization of the covalent SARS-CoV-2 3CLpro inhibitors from Ginkgo biloba extract via integrating chemoproteomic and biochemical approaches
2023 · Ya-Ni Zhang, Guang-Hao Zhu, et al. · Phytomedicine · 22
Chemo- and Site-Selective Lysine Modification of Peptides and Proteins under Native Conditions Using the Water-Soluble Zolinium
2022 · Haiguo Sun, Mengyu Xi, et al. · Journal of Medicinal Chemistry · 19
Discovery of a novel chalcone-derived covalent Keap1 binder for mitigating cisplatin-induced mitochondrial dysfunction and nephrotoxicity
2025 · Yanyan Deng, Leizhi Xu, et al. · Redox Biology · 18
Discovery of the covalent SARS‐CoV‐2 Mpro inhibitors from antiviral herbs via integrating target‐based high‐throughput screening and chemoproteomic approaches
2023 · Ya‐Ni Zhang, Guang‐Hao Zhu, et al. · Journal of Medical Virology · 14
Discovery of baicalein derivatives as novel inhibitors against human pancreatic lipase: Structure-activity relationships and inhibitory mechanisms
2024 · Xiao-Ya Qin, Rong Zhu, et al. · International Journal of Biological Macromolecules · 13
Discovery of 4’-trifluoromethylchalcones as novel, potent and selective hCYP1B1 inhibitors without concomitant AhR activation
2023 · Yue Wu, Jin-Hui Shi, et al. · European Journal of Medicinal Chemistry · 13
Discovery and mechanism of action of Thonzonium bromide from an FDA-approved drug library with potent and broad-spectrum inhibitory activity against main proteases of human coronaviruses
2022 · Ruyu Wang, Guanglei Zhai, et al. · Bioorganic Chemistry · 12
Super-Resolution Imaging of Autophagy by a Preferred Pair of Self-Labeling Protein Tags and Fluorescent Ligands
2022 · Huizi Man, Lin Zhou, et al. · Analytical Chemistry · 12
Deciphering the Effective Constituents and Mechanisms of Portulaca oleracea L. for Treating NASH via Integrating Bioinformatics Analysis and Experimental Pharmacology
2022 · Xiaoli He, Yiren Hu, et al. · Frontiers in Pharmacology · 12
A series of (NHC)Pd(N˄O)(OAc) complexes: synthesis, characterization and catalytic activities towards desulfinative Sonogashira coupling of arylsulfonyl hydrazides with arylalkynes
2020 · Jin Yang, Jian‐Zhong Lu, et al. · Applied Organometallic Chemistry · 12
Discovery of seven-membered ring berberine analogues as highly potent and specific hCES2A inhibitors
2023 · Yun Yang, Yuan Xiong, et al. · Chemico-Biological Interactions · 11
Methylophiopogonanone A is a naturally occurring broad‐spectrum inhibitor against human UDP‐glucuronosyltransferases: Inhibition behaviours and implication in herb‐drug interactions
2021 · Qi‐Hang Zhou, Guang‐Hao Zhu, et al. · Basic & Clinical Pharmacology & Toxicology · 10
Characterization of the glucuronidating pathway of pectolinarigenin, the major active constituent of the Chinese medicine Daji, in humans and its influence on biological activities
2023 · Peiqi Liu, Qian Li, et al. · Journal of Ethnopharmacology · 9
Discovery of Isojacareubin as a covalent inhibitor of SARS‐CoV‐2 main protease using structural and experimental approaches
2023 · Abbas Khan, Wang Heng, et al. · Journal of Medical Virology · 9
Discovery of baicalein derivatives as novel covalent inhibitors of SARS CoV-2 Mpro: Structure-activity relationships and inhibitory mechanisms
2025 · Zhao-Qin Zhang, Guang-Hao Zhu, et al. · Bioorganic Chemistry · 8
Human UDP-glucuronosyltransferase 1As catalyze aristolochic acid D O-glucuronidation to form a lesser nephrotoxic glucuronide
2024 · Dong-Zhu Tu, Pei-Qi Liu, et al. · Journal of Ethnopharmacology · 8
Works count: 59
Citation count: 1,006
H-index: 13
I10-index: 21
Year
Topic
Type